Healthcare provider profile · identity verified

Jeanine Ernest, MD

Internal Medicine · ALMA, MI · NPI 1235367269

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	832	213
Levothyroxine Sodium	Levothyroxine Sodium	784	182
Lisinopril	Lisinopril	710	178
Amlodipine Besylate	Amlodipine Besylate	449	117
Omeprazole	Omeprazole	446	118
Losartan Potassium	Losartan Potassium	339	88
Hydrochlorothiazide	Hydrochlorothiazide	292	77
Sertraline Hcl	Sertraline Hcl	282	76
Simvastatin	Simvastatin	271	72
Pravastatin Sodium	Pravastatin Sodium	243	54
Gabapentin	Gabapentin	235	42
Metformin Hcl	Metformin Hcl	220	59
Metformin Hcl Er	Metformin Hcl	214	61
Mounjaro	Tirzepatide	206	33
Pantoprazole Sodium	Pantoprazole Sodium	192	58
Metoprolol Succinate	Metoprolol Succinate	188	49
Metoprolol Tartrate	Metoprolol Tartrate	169	48
Furosemide	Furosemide	159	46
Tramadol Hcl	Tramadol Hcl	147	24
Trazodone Hcl	Trazodone Hcl	144	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	143	20
Ozempic	Semaglutide	143	26
Tamsulosin Hcl	Tamsulosin Hcl	141	38
Albuterol Sulfate Hfa	Albuterol Sulfate	137	46
Glipizide	Glipizide	132	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	126	36
Meloxicam	Meloxicam	126	24
Atenolol	Atenolol	120	30
Eliquis	Apixaban	116	27
Montelukast Sodium	Montelukast Sodium	113	29
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	112	27
Potassium Chloride	Potassium Chloride	107	41
Lorazepam	Lorazepam	102	17
Citalopram Hbr	Citalopram Hydrobromide	100	25
Alprazolam	Alprazolam	98	16
Carvedilol	Carvedilol	98	26
Allopurinol	Allopurinol	97	22
Alendronate Sodium	Alendronate Sodium	96	34
Rosuvastatin Calcium	Rosuvastatin Calcium	85	21
Escitalopram Oxalate	Escitalopram Oxalate	82	20
Fluticasone Propionate	Fluticasone Propionate	82	32
Duloxetine Hcl	Duloxetine Hcl	80	21
Hydralazine Hcl	Hydralazine Hcl	76	15
Buspirone Hcl	Buspirone Hcl	71	18
Clopidogrel	Clopidogrel Bisulfate	68	20
Fluoxetine Hcl	Fluoxetine Hcl	66	17
Bisoprolol Fumarate	Bisoprolol Fumarate	64	16
Paroxetine Hcl	Paroxetine Hcl	64	18
Zolpidem Tartrate	Zolpidem Tartrate	64	suppressed
Clonazepam	Clonazepam	60	suppressed
Ibuprofen	Ibuprofen	59	16
Tizanidine Hcl	Tizanidine Hcl	59	15
Famotidine	Famotidine	57	15
Ropinirole Hcl	Ropinirole Hcl	57	13
Trulicity	Dulaglutide	54	14
Xarelto	Rivaroxaban	54	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	13
Celecoxib	Celecoxib	52	14
Warfarin Sodium	Warfarin Sodium	50	16
Januvia	Sitagliptin Phosphate	48	16
Venlafaxine Hcl Er	Venlafaxine Hcl	48	13
Donepezil Hcl	Donepezil Hcl	47	13
Spironolactone	Spironolactone	44	11
Chlorthalidone	Chlorthalidone	43	12
Memantine Hcl	Memantine Hcl	43	suppressed
Ventolin Hfa	Albuterol Sulfate	43	15
Linzess	Linaclotide	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	11
Lovastatin	Lovastatin	42	suppressed
Propranolol Hcl	Propranolol Hcl	41	12
Glimepiride	Glimepiride	40	suppressed
Pregabalin	Pregabalin	39	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	11
Synthroid	Levothyroxine Sodium	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Novolog Flexpen	Insulin Aspart	33	11
Nystatin	Nystatin	33	23
Prednisone	Prednisone	33	29
Azithromycin	Azithromycin	32	25
Diazepam	Diazepam	31	suppressed
Azelastine Hcl	Azelastine Hcl	29	11
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	23
Terazosin Hcl	Terazosin Hcl	28	suppressed
Temazepam	Temazepam	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Glipizide Er	Glipizide	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Finasteride	Finasteride	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Rybelsus	Semaglutide	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Estradiol	Estradiol	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Torsemide	Torsemide	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	18
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Jantoven	Warfarin Sodium	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	14
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Valsartan	Valsartan	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Baclofen	Baclofen	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fluconazole	Fluconazole	16	14
Loperamide	Loperamide Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Risperidone	Risperidone	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Bethanechol Chloride	Bethanechol Chloride	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Clonidine	Clonidine	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Naproxen	Naproxen	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	12	suppressed
Nurtec Odt	Rimegepant Sulfate	12	suppressed
Primidone	Primidone	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Colchicine	Colchicine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error